Results 1 to 10 of about 95,804 (302)
Epidemiology of Haemophilus ducreyi Infections [PDF]
Emerging Infectious Diseases, 2016 The global epidemiology of Haemophilus ducreyi infections is poorly documented because of difficulties in confirming microbiological diagnoses. We evaluated published data on the proportion of genital and nongenital skin ulcers caused by H.
Camila González-Beiras +4 more
doaj +4 more sources
Multi-Component Vaccine Candidates Against Non-Typeable Haemophilus influenzae [PDF]
VaccinesBackground: Haemophilus influenzae (Hi), a Gram-negative bacterium, is divided into two broad categories: encapsulated and non-capsulated isolates, also called non-typeable Hi isolates (NTHi).
Nouria Belkacem +2 more
doaj +2 more sources
Haemophilus influenzaeInfections [PDF]
New England Journal of Medicine, 1972 Of the six typeable strains of this organism, type b is the most virulent, accounting for 95% of serious infections in children. Unexpectedly, in adults, nearly two thirds of isolates from blood and CSF were found to be nontypeable. The spectrum of clinical disease associated with type b and nontypeable strains is discussed.
J D, Connor, W L, Nyhan
+10 more sources
Methodological establishment and diagnostic value of a multiplex fluorescent PCR assay for the detection of three fastidious respiratory pathogens. [PDF]
PLoS ONEBackgroundStreptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis are common fastidious bacteria responsible for respiratory tract infections, particularly in children and immunocompromised individuals.
Jingchao Shi +6 more
doaj +2 more sources
Upper Airways Microbiota in Antibiotic-Naive Wheezing and Healthy Infants from the Tropics of Rural Ecuador [PDF]
, 2012 Background: Observations that the airway microbiome is disturbed in asthma may be confounded by the widespread use of antibiotics and inhaled steroids.
Arias, C +6 more
core +18 more sources
The rapid rebound of invasive meningococcal disease in France at the end of 2022
Journal of Infection and Public Health, 2023 Background: Invasive meningococcal disease (IMD) cases declined upon the implementation of non-pharmaceutical measures to control the COVID-19 pandemic. A rebound in IMD cases was feared upon easing these measures.
Samy Taha +6 more
doaj +1 more source
Haemophilus influenzae type b (Hib) seroprevalence in France: impact of vaccination schedules
BMC Infectious Diseases, 2021 Background Haemophilus influenzae serotype b (Hib) conjugate vaccine was introduced in France in 1992 as a 3 + 1 scheme at 2, 3, and 4 months (primary vaccination) with a booster at the age of 16–18 months. The vaccination was simplified in 2013 to a 2 +
Eva Hong +6 more
doaj +1 more source
npj Vaccines, 2022 Since January 2018, mandatory vaccination against meningococci serogroup C has been implemented in France for children
Samy Taha +2 more
doaj +1 more source
Product review on the IMD serogroup B vaccine Bexsero®
Human Vaccines & Immunotherapeutics, 2022 Bexsero® is a multicomponent vaccine composed of four major proteins of Neisseria meningitidis: the fHbp, NHBA, NadA and PorA. This vaccine was licensed against invasive meningococcal disease (IMD) due to serogroup B isolates.
Ala-Eddine Deghmane, Muhamed-Kheir Taha
doaj +1 more source
Haemophilus parainfluenzae biliary tract infections [PDF]
Journal of Clinical Microbiology, 1996 Piérard, Denis +5 more
openaire +3 more sources